The Morning Dispatch

Every weekday morning, Mary Trimble and Grayson Logue provide an essential news briefing, along with original reporting and analysis on the day’s biggest stories.

By signing up with your email, you agree to The Dispatch’s privacy policy

Iran’s Complicated Web of Terror

As regional tensions escalate, Israel and the U.S. focus on Tehran.

The Copyright Expiration Free-for-All

A look at the legal oddity known as Public Domain Day.

Jimmy Lai’s Trial Spotlights Beijing’s Reach

The pro-democracy advocate faces national security charges in Hong Kong.

The Dispatch’s Best of 2023

The culture and content we enjoyed the most this year.

New Year, New Economic Forecast

Economists and everyday Americans try to make heads or tails of the economy.

An End-of-Year Migrant Surge

Border crossings continue to reach record levels while Washington struggles to address the crisis.

Merry Christmas, Happy Holidays

Dispatch writers share their favorite holiday traditions.

Colorado Kicks Trump Off the Ballot

The controversial decision held that the 14th Amendment renders the former president ineligible to run for reelection.

Trump’s ‘Poisonous’ Campaign Rhetoric

Is Trump’s increasingly extreme language a campaign tactic or a preview of his governing style?

Israel Faces Renewed Calls for Hostage Negotiations

The IDF’s accidental killing of three hostages sparks protests in Tel Aviv, but Israeli leaders remain steadfast in their desire to see Hamas eliminated.

The Biden Administration Invests in High-Speed Rail

‘It’s all too easy to be deceived by what we see in other countries.’

Zelensky Delivers His Wish List to Washington

The Ukrainian president makes a personal pitch for continued military aid.

To Pay or Not To Pay … College Athletes

The NCAA and Congress look to formalize name, image, likeness rules.

Venezuela Squeezes Guyana

Tensions are rising in the disputed Essequibo region, sparking regional unease.

Biden Targets the Pharmaceutical Industry

A proposed rule could allow major government interference in drug patents.

Antisemitism Beleaguers the Ivies 

Harvard, Penn, and MIT face the fallout of their presidents’ disastrous congressional testimonies.